Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Intercept Pharmaceuticals (NASDAQ:ICPT) in connection to alleged violations of securities laws by ICPT. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Intercept Pharmaceuticals between April 1, 2016, and May 2, 2017.…

Read More